标题
A small molecule inhibitor of HER3: a proof-of-concept study
作者
关键词
-
出版物
BIOCHEMICAL JOURNAL
Volume 477, Issue 17, Pages 3329-3347
出版商
Portland Press Ltd.
发表日期
2020-08-20
DOI
10.1042/bcj20200496
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
- (2020) Lucía Gandullo‐Sánchez et al. EMBO Molecular Medicine
- Prospects for pharmacological targeting of pseudokinases
- (2019) Jennifer E. Kung et al. NATURE REVIEWS DRUG DISCOVERY
- Tracing the origin and evolution of pseudokinases across the tree of life
- (2019) Annie Kwon et al. Science Signaling
- ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics
- (2019) Nicolas Kiavue et al. ONCOGENE
- Pseudokinases: a tribble‐edged sword
- (2019) Laura Richmond et al. FEBS Journal
- MEK drives BRAF activation through allosteric control of KSR proteins
- (2018) Hugo Lavoie et al. NATURE
- Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface
- (2018) Jeroen Claus et al. eLife
- The structure of serum resistance-associated protein and its implications for human African trypanosomiasis
- (2018) Sebastian Zoll et al. Nature Microbiology
- Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells
- (2018) Daniel M. Foulkes et al. Science Signaling
- The architecture of EGFR’s basal complexes reveals autoinhibition mechanisms in dimers and oligomers
- (2018) Laura C. Zanetti-Domingues et al. Nature Communications
- Pseudokinases: update on their functions and evaluation as new drug targets
- (2017) Dominic P Byrne et al. Future Medicinal Chemistry
- RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
- (2017) Ting Jin et al. Nature Communications
- A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
- (2017) Jose Mauricio Mota et al. Oncotarget
- Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling
- (2016) Neil S. Dhawan et al. NATURE
- Structural Basis for the Non-catalytic Functions of Protein Kinases
- (2016) Jennifer E. Kung et al. STRUCTURE
- Going for broke: targeting the human cancer pseudokinome
- (2015) Fiona P. Bailey et al. BIOCHEMICAL JOURNAL
- Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain
- (2015) John S. Tokarski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum
- (2015) A Ruiz-Saenz et al. ONCOGENE
- Inhibition of ErbB3 by a monoclonal antibody that locks the extracellular domain in an inactive configuration
- (2015) Sangwon Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapy
- (2014) Jeroen Claus et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Pharmacological targeting of the pseudokinase Her3
- (2014) Ting Xie et al. Nature Chemical Biology
- HER3, serious partner in crime
- (2014) Arjan Kol et al. PHARMACOLOGY & THERAPEUTICS
- Day of the dead: pseudokinases and pseudophosphatases in physiology and disease
- (2014) Veronika Reiterer et al. TRENDS IN CELL BIOLOGY
- A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties
- (2013) James M. Murphy et al. BIOCHEMICAL JOURNAL
- Pseudokinase drug intervention: a potentially poisoned chalice
- (2013) Jeroen Claus et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Oncogenic ERBB3 Mutations in Human Cancers
- (2013) Bijay S. Jaiswal et al. CANCER CELL
- The Gray Institute ‘open’ high-content, fluorescence lifetime microscopes
- (2013) P.R. BARBER et al. JOURNAL OF MICROSCOPY
- RAF Inhibitor-Induced KSR1/B-RAF Binding and Its Effects on ERK Cascade Signaling
- (2011) Melissa M. McKay et al. CURRENT BIOLOGY
- Automated multidimensional single molecule fluorescence microscopy feature detection and tracking
- (2011) Daniel J. Rolfe et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK
- (2011) Damian F. Brennan et al. NATURE
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
- (2010) Fumin Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A dimerization-dependent mechanism drives RAF catalytic activation
- (2009) Thanashan Rajakulendran et al. NATURE
- Inhibitor hijacking of Akt activation
- (2009) Tatsuya Okuzumi et al. Nature Chemical Biology
- PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity
- (2009) Angus J M Cameron et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
- (2009) N. Jura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation
- (2009) E. Zeqiraj et al. SCIENCE
- ATP and MO25α Regulate the Conformational State of the STRADα Pseudokinase and Activation of the LKB1 Tumour Suppressor
- (2009) Elton Zeqiraj et al. PLOS BIOLOGY
- Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
- (2008) D L Wheeler et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More